Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, indicating a minor version bump with no visible user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a note that PubMed publications are auto-filled and may not relate to the study, and updated the revision label from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the page-wide government funding lapse notice that previously appeared on the page. Core study details, eligibility criteria, and related content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedA Results section has been added with updated outcome measures. The Study Record Dates reflect the latest status, including Results First Posted 2025-04-04.SummaryDifference0.5%

- Check92 days agoChange DetectedIntroducing a government funding status notice and a new version tag (v3.2.0) with removal of the previous version (v3.1.0).SummaryDifference3%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.